For decades we have known that an enzymatic process called glycosylation is abnormal in cancerous cells and other diseased human tissues, yet therapeutic strategies addressing this biochemical change have remained elusive. An attempt to modify the glycosylation process has become a new target for therapeutics. This theme will address a range of targets for human health by applying knowledge gained in glycomics over the last decade, with the aim to bridge the gap between fundamental advances and therapeutic applications in cancer, inflammation and cardiovascular disease.
If you are experiencing an issue on the current page, you can report it here. Explain what the issue is and a report will be sent to support@forum.glyconet.ca. The following information will automatically be sent:
Si vous rencontrez un problème sur la page actuelle, vous pouvez le signaler ici. Expliquez la nature du problème; un rapport sera envoyé à support@forum.glyconet.ca. Les renseignements suivants seront automatiquement transmis:
-
User/Email (if logged in)
Utilisateur/courriel (si connecté)
-
Browser Information
Information sur le navigateur
-
Url of Page
URL de la page
-
Screenshot of page
Capture d’écran de la page
Additional Comments:Commentaires supplémentaires: